The present invention relates to an oral composite preparation comprising empagliflozin and sitagliptin as effective ingredients. According to the present invention, the preparation is advantageous in pharmacological aspects not only because the drugs are contained in a monolayer to exhibit the effect of alleviating blood glucose level instantly and sustainably, but also because the storage stability and content uniformity of the active ingredients are improved.La présente invention concerne une préparation composite orale comprenant l'empagliflozine et la sitagliptine en tant qu'ingrédients efficaces. Selon la présente invention, la préparation est avantageuse selon des aspects pharmacologiques non seulement parce que les médicaments sont contenus dans une monocouche afin de présenter l'effet d'atténuation instantanée et durable du taux de glucose sanguin, mais aussi parce que la stabilité au stockage et l'uniformité de la teneur des principes actifs sont améliorées.본 발명은 활성성분으로 엠파글리플로진 및 시타글립틴을 포함하는 경구용 복합제제에 관한 것으로, 본 발명에 따르면, 이들 약물을 단일층에 포함하여 즉각적이고 지속적인 혈당개선 효과를 나타낼 뿐 아니라, 활성성분의 보관 안정성 및 함량 균일성이 개선되어 약제학적 측면에서 유리한 장점이 있다.
